Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best healthcare stocks with the highest upside. Goldman Sachs initiated ...

Fullerton’s Rosary Academy marks 60 years of educating female leaders

The Fullerton all-girls Catholic school honored alumna Katie Webb Brundige, co-founder of RAD Camp (Rising Against ...

Aardvark Therapeutics Expands Phase 3 HERO Trial Eligibility for ARD-101 in Prader-Willi Syndrome After FDA Protocol Alignment

Aardvark Therapeutics Inc. (NASDAQ:AARD) is one of the best young stocks with huge upside potential. On October 8, Aardvark ...

Katie Price reveals Harvey has lost 1.5st after starting fat jabs and has smashed THREE iPads in one week

KATIE Price has revealed that her son Harvey has lost 1.5 stone after starting fat jabs. She also revealed how he smashed ...

Telethon 2025: Charlie Cains remarkable journey living with two rare genetic conditions since birth

I accepted very quickly that Charlie was disabled and I accepted the worst. I didn’t try to hang onto the hope that he was ...

Katie Price starting Harvey on CBD gummies as he became 'nice and chilled' on them

Harvey Price, who is autistic and has Prader-Willi syndrome, accidentally took two of mum Katie Price's CBD gummies and they ...
Labiotech.eu

Prader Willi syndrome: five much-anticipated therapies poised for approval

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...
Japan Today

1 gene, 1 disease no more – acknowledging the full complexity of genetics could improve and personalize medicine

One gene causes one trait or a specific illness. When doctors use genetics, it’s usually to try to identify a disease-causing gene to help guide diagnosis and treatment. But for most health conditions ...
TMCnet

Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the appointment of biopharmaceutical ...

Soleno: Blockbuster Launch In Progress

See more on the latest on Soleno Therapeutics (SLNO) stock after VYKAT XR approval. Learn why post-approval commercialization ...

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...